Diclofenac (50mg)
Diclofenac Sodium 50 mg Tablet is used for pain relief. It relieves pain in conditions like headache, mild migraine, muscle pain, dental pain, rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, or painful menses.
1 Strip of 1 Tablet
Troikaa Pharmaceuticals Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Diclofenac Sodium 50 mg Tablet is to be taken with food.
Diclofenac Sodium 50 mg Tablet is a non-steroidal anti-inflammatory drugs (NSAID). It works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling).
Related Warnings
Taking diclofenac with alcohol can increase your risk of stomach bleeding.
Diclofenac Sodium 50 mg Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Diclofenac Sodium 50 mg Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Do not drive unless you are feeling well.
Diclofenac Sodium 50 mg Tablet may cause headaches, blurred vision, dizziness or drowsiness in some patients. This may affect your ability to drive.
Diclofenac Sodium 50 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Diclofenac Sodium 50 mg Tablet may be needed. Please consult your doctor.
Diclofenac Sodium 50 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Diclofenac Sodium 50 mg Tablet may be needed. Please consult your doctor.
Regular monitoring of liver function tests is recommended in patients with liver disease if this medicine is to be taken for a long time.
